Business Context and Reporting Period
Company: CytoSorbents Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: March 28, 2017
Event: Issuance of U.S. Patent No. 9,604,196 entitled "Size Selective Hemocompatible Polymer System."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate event rather than financial performance.
Material Changes
No material financial changes versus the prior comparable period are reported in this document. The primary change is the addition of intellectual property assets via the new patent issuance.
Guidance, Outlook, and Risks
Management Commentary: The Company announced the patent issuance on March 28, 2017. The full press release is filed as Exhibit 99.1.
Risks and Contingencies: No specific risks or contingencies are detailed in the body of this 8-K filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for details on the commercial implications of Patent No. 9,604,196.
- Verify the scope of the "Size Selective Hemocompatible Polymer System" to assess competitive advantage.
- Check subsequent filings for any financial impact related to the patent maintenance or licensing.